Euclidean Technologies Management, LLC Biogen Inc. Transaction History

Euclidean Technologies Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$282.99 - $369.05 $209,129 - $272,727	-739 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$259.0 - $414.71 $191,401 - $306,470	739 New	739 $256,000
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $1.86 Million - $2.8 Million	-7,860 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $1.73 Million - $2.39 Million	7,860 New	7,860 $2.33 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Euclidean Technologies Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Euclidean Technologies Management, LLC with notifications on news.